Drug Alerts and Special Reports

The BuyandBill.com newsletter provides important information pertaining to key reimbursement related events for new and existing office-administered products. Our newsletter is sent from BuyandBill.com on behalf of pharma manufacturers. The newsletter includes the following information: C-Code alerts, J-code alerts, NCCN alerts, New NDC alerts, Updates on Pricing information, and more. Click here to opt in to our newsletter.

Announcing a price change | This message is being sent on behalf of Dynavax Technologies – 2/27/24

Announcing Permanent J-Code for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) – 1/24/24

Temporary C-Code for a New 4F-PCC Available January 1, 2024 – 1/22/24

Samsung Bioepis Biosimilar Market Report 4th Edition, Q1 2024 – 1/17/24

J9259 Paclitaxel protein-bound particles (American Regent) – 1/10/24

CMS Granted J-Codes for Chiesi Products – 1/9/24

Announcing a new Wholesale Acquisition Cost (WAC) for NEXPLANON® (etonogestrel implant) 68 mg Radiopaque – 1/2/24

Sponsored Message: New FDA Approval in Locally Advanced/Metastatic Urothelial Cancer (mUC) – 1/3/24

Permanent J-Code for BARHEMSYS® (amisulpride injection): Available January 1, 2024 – 12/20/2

Temporary C-Code for YCANTH® (cantharidin): C9164 – 12/13/23

Announcing a Price Change for Paragard® (intrauterine copper contraceptive) – 12/12/23

XACIATO™ for the treatment of Bacterial vaginosis – 12/5/23